RxDoctor Payments Data

Jessica Coleman

Family · Brunswick, GANPI 1992218986

Payments from drug & device makers

$5,346in general payments, 2019–2025

Across 225 payments — averaging $23.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$925
  • AbbVie$869
  • Axsome Therapeutics, Inc.$541
  • Takeda Pharmaceuticals U.S.A., Inc.$515
  • Otsuka America Pharmaceutical, Inc.$435
  • Novo Nordisk$420
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$5,346100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,346 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole16$25,909
VraylarCariprazine Hcl16$21,193
Vilazodone Hcl20$2,566
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$750
Oxcarbazepine25$470
Quetiapine Fumarate24$391
Buspirone Hcl26$315
Hydroxyzine Hcl19$301
Trazodone Hcl29$262
Prazosin Hcl25$207
Gabapentin19$204
Lamotrigine28$142
Alprazolam30$123
Temazepam11$121
Bupropion XlBupropion Hcl13$100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$435$25,90916 claims
AbbVieVraylar$869$21,19316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Brunswick

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →